Harbour Investments, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Harbour Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $2,327 - $4,087	-28 Reduced 38.36%	45 $7,000
Q4 2021 Feb 16, 2022	BUY	$99.73 - $148.48 $7,280 - $10,839	73 New	73 $10,000
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $791,195 - $1.11 Million	-8,004 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $1,578 - $2,520	-24 Reduced 0.3%	8,004 $777,000
Q1 2021 Aug 17, 2021	BUY	$64.07 - $91.75 $398,002 - $569,951	6,212 Added 342.07%	8,028 $549,000
Q1 2021 May 12, 2021	BUY	$64.07 - $91.75 $116,351 - $166,618	1,816 New	1,816 $124,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.